Orange Book product · Generic (ANDA)
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
At a glance
Jan 31, 1996
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 31, 1996
30 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength
0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT
Application
ANDA 064047
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- 2005NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDINGeneric (ANDA)
ANDA 065187 · SCIEGEN PHARMS
- 1988NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDINGeneric (ANDA)
ANDA 062818 · IPHARM
- 1987NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDINGeneric (ANDA)
ANDA 062788 · WATSON LABS
- 1982NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDINGeneric (ANDA)
ANDA 062383 · PHARMAFAIR
- —NEO-POLYCINGeneric (ANDA)
ANDA 060427 · DOW PHARM
- —NEOSPORINGeneric (ANDA)
ANDA 060582 · MONARCH PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
